Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients Wi… (NCT07063537) | Clinical Trial Compass
RecruitingNot Applicable
Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Canada60 participantsStarted 2024-12-14
Plain-language summary
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are:
* Can both devices produce similar results in terms of detecting visual field defects and progression?
* Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices?
Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \>18 years of age
* diagnosis of primary open-angle glaucoma
* ability to perform visual field testing
* capacity to provide informed consent to research protocol
Exclusion Criteria:
* diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy
* previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
* significant media opacity
* pregnancy
* seizure disorder
* cardiac pacemaker/other implantable device
* severe vertigo/balance disorder
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual field point-wise threshold values
Timeframe: Measured during each visual field test on visits 1 through 5 (throughout study completion, average 2 months)
2
Global indices of visual field loss
Timeframe: Measured during each visual field test on visits 1 through 5 (throughout study completion, average 2 months)
3
Reliability Indices
Timeframe: Measured during each visual field test on visits 1 through 5 (throughout study completion, average 2 months)